BIOMAT Database Logo BIOMAT Database Logo

Hyperresponsivity to the serotonin agonist m-chlorophenylpiperazine in Alzheimer's disease. A controlled study. 1989

B A Lawlor, and T Sunderland, and A M Mellow, and J L Hill, and S E Molchan, and D L Murphy
Unit on Geriatric Psychopharmacology, National Institute of Mental Health, Bethesda, Md. 20892.

The serotonin agonist m-chlorophenylpiperazine (mCPP) was administered intravenously to 12 patients with Alzheimer's disease and ten age-matched controls. It produced distinct behavioral effects in both treatment groups; however, significantly greater responsivity to mCPP was found in patients with Alzheimer's disease than in controls in measures of psychomotor activation, restlessness, and perceptual abnormalities. Significant and similar increases in plasma prolactin and cortisol levels were found in both patients with Alzheimer's disease and controls following the administration of mCPP vs placebo. Furthermore, blood pressure and pulse changes following mCPP were not significantly different between the groups. Elderly controls, however, did show a significantly greater temperature response following mCPP than did patients with Alzheimer's disease. The overall cognitive effects of mCPP were minimal; however, mCPP produced significantly greater worsening in recent memory and knowledge memory in patients with Alzheimer's disease than in controls. These findings could not be explained by pharmacokinetic differences across populations, because plasma concentrations of mCPP were similar in patients with Alzheimer's disease and controls. The increased behavioral responsivity but unchanged neuroendocrine or other physiologic responsivity to mCPP may be related to damaged brain serotonin neurons or other neuronal systems that interact with serotonin neurons that have been found in postmortem and biopsy studies of patients with Alzheimer's disease.

UI MeSH Term Description Entries
D008297 Male Males
D010555 Personality Inventory Check list, usually to be filled out by a person about himself, consisting of many statements about personal characteristics which the subject checks. Edwards Personal Preference Schedule,Myers-Briggs Type Indicator,Indicator, Myers-Briggs Type,Inventories, Personality,Inventory, Personality,Myers Briggs Type Indicator,Personality Inventories
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D011674 Pulse The rhythmical expansion and contraction of an ARTERY produced by waves of pressure caused by the ejection of BLOOD from the left ventricle of the HEART as it contracts. Pulses
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

B A Lawlor, and T Sunderland, and A M Mellow, and J L Hill, and S E Molchan, and D L Murphy
Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans.
December 1985, The Journal of clinical endocrinology and metabolism,
B A Lawlor, and T Sunderland, and A M Mellow, and J L Hill, and S E Molchan, and D L Murphy
The serotonin agonist m-chlorophenylpiperazine (mCPP) binds to serotonin transporter sites in human brain.
November 1995, Neuroreport,
B A Lawlor, and T Sunderland, and A M Mellow, and J L Hill, and S E Molchan, and D L Murphy
Induction of migrainelike headaches by the serotonin agonist m-chlorophenylpiperazine.
June 1988, Clinical pharmacology and therapeutics,
B A Lawlor, and T Sunderland, and A M Mellow, and J L Hill, and S E Molchan, and D L Murphy
Neuroendocrine response to the serotonin agonist M-chlorophenylpiperazine in women with menstrual status migrainosus.
July 2003, Neuroendocrinology,
B A Lawlor, and T Sunderland, and A M Mellow, and J L Hill, and S E Molchan, and D L Murphy
The serotonin agonist, M-chlorophenylpiperazine, markedly increases levels of plasma catecholamines in the conscious rat.
October 1988, Neuropharmacology,
B A Lawlor, and T Sunderland, and A M Mellow, and J L Hill, and S E Molchan, and D L Murphy
Intravenous administration of the serotonin agonist m-chlorophenylpiperazine (mCPP) increases extracellular serotonin in the diencephalon of awake rats.
December 1993, Neuropharmacology,
B A Lawlor, and T Sunderland, and A M Mellow, and J L Hill, and S E Molchan, and D L Murphy
m-Chlorophenylpiperazine as a probe of serotonin function.
December 1991, Biological psychiatry,
B A Lawlor, and T Sunderland, and A M Mellow, and J L Hill, and S E Molchan, and D L Murphy
Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans.
January 1986, Psychopharmacology,
B A Lawlor, and T Sunderland, and A M Mellow, and J L Hill, and S E Molchan, and D L Murphy
Clozapine treatment and its effect on neuroendocrine responses induced by the serotonin agonist, m-chlorophenylpiperazine.
June 1994, Biological psychiatry,
B A Lawlor, and T Sunderland, and A M Mellow, and J L Hill, and S E Molchan, and D L Murphy
Allelic variants of the serotonin(2C) receptor and neuroendocrinological responses to the serotonin(2C) receptor agonist m-chlorophenylpiperazine in healthy male volunteers.
November 2002, Pharmacopsychiatry,
Copied contents to your clipboard!